Background and Purpose-There is an overlap between stroke and coronary heart disease, but the exact prevalence of coronary artery disease in patients with nonfatal cerebral infarction is unclear, particularly when there is no known history of coronary heart disease. Methods-We consecutively enrolled 405 patients presenting with acute cerebral infarction documented by neuroimaging who underwent carotid and femoral artery, thoracic, and abdominal aorta ultrasound examinations.
I
n the early years after a stroke, the most common vascular event is another stroke. 1 However, at 5 years there are twice as many deaths from myocardial infarction as there are from recurrent stroke. 2, 3 Among 846 ischemic stroke patients included in the Virtual International Stroke Trials Archive, 35 (4.1%) died from cardiac causes at 12 weeks. 4 Although this risk is welldocumented in patients with stroke [5] [6] [7] and in subjects with carotid atherosclerosis, 8 how much of it can be predicted from medical history or from the presence of arterial plaque in extracardiac locations (such as carotid or femoral arteries) and how much is related to "silent" asymptomatic coronary artery disease is unknown. The exact prevalence of silent coronary atherosclerosis in stroke patients with no known coronary heart disease is not known. One autopsy series found a high prevalence of coronary artery disease in patients with fatal cerebral infarction, which was even higher in the presence of carotid or cerebral artery atherosclerosis. 9 However, there has been no systematic angiography evaluation of the prevalence of coronary artery disease in a large group of consecutive patients with nonfatal cerebral infarction with no known history of coronary heart disease. Our aim was to describe the prevalence of coronary artery disease in a large cohort of consecutive patients with nonfatal cerebral infarction, and to assess whether the presence of systemic atherosclerosis in extracardiac locations affected this prevalence.
Patients and Methods

Study Population
The Asymptomatic Myocardial Ischemia in Stroke and Atherosclerotic Disease (AMISTAD) study was a prospective, single-center registry. All consecutively enrolled patients 18 years of age or older admitted with an acute ischemic stroke documented by neuroimaging and a Rankin scale Ͻ5 were offered the opportunity to participate and were enrolled within 10 days of symptom onset after providing written informed consent. Pregnant women, patients with other nonvascular diseases associated with a life expectancy of Ͻ30 months, and patients with cerebral infarction attributable to carotid or vertebral artery dissection or secondary to a revascularization procedure were excluded. The 
Evaluation of Atherosclerotic Disease Burden
All patients had a standardized evaluation. Carotid atherosclerosis was evaluated by ultrasound examination of both extracranial carotid arteries. Patients were categorized as having either a normal carotid artery wall or an atherosclerotic plaque with or without stenosis. We used the term "plaque" to describe the anatomic lesion of an artery produced by atherosclerotic disease, regardless of whether they induced an arterial stenosis or a lumen narrowing. Stenoses were measured on horizontal cross-sections based on residual lumen relative to the external diameter of the artery. Coronary atherosclerosis was evaluated by coronary angiography in patients with no known history of coronary heart disease (history of acute coronary syndrome, myocardial infarction, or previous coronary revascularization). Results were categorized into absence of plaque, plaque with or without stenosis of any degree, stenosis 1% to 49%, 50% to 69%, 70% to 99%, and 100% (total occlusion). Patients who had a known history of coronary heart disease did not undergo coronary angiography but were grouped in the analyses with patients with coronary plaque. Atherosclerosis of the aorta was evaluated by transesophageal echocardiography (aortic arch and thoracic descending aorta) and abdominal ultrasound (abdominal aorta, including measurement of infrarenal aortic diameter). Femoral atherosclerosis was evaluated by ultrasonography. Results of the aortic arch examination were categorized into absence of plaque, plaque Ͻ4 mm in thickness, or plaque Ն4 mm.
Risk Factor Evaluation
All patients had an evaluation of their demographic characteristics and risk factors after a face-to-face interview and using a structured questionnaire. Blood samples were collected in fasting conditions at enrollment for evaluation of the lipid profile before any change in lipid-lowering treatment. Arterial hypertension was defined as treated hypertension at discharge, diabetes was defined as treated diabetes at discharge, and hypercholesterolemia was defined as previous lipid-lowering treatment or admission low-density lipoprotein cholesterol Ͼ160 mg/dL. Smoking history was classified as current (any smoking in the past 9 months), past, or never smokers. Family history (first-degree relative) of stroke or myocardial infarction was recorded.
Study Conduct and Funding
Screening and enrollment were performed with the assistance of 2 full-time clinical research assistants, supervised by a data manager. They were in charge of verifying enrollment criteria; ensuring completeness of the case report forms; collection of risk factor data and laboratory test results; arranging neuroimaging, carotid, aortic, and femoral ultrasonography examinations and coronary angiography; and collecting the reports. Data audit was performed independently by another clinical research assistant. Carotid ultrasonography examinations were performed by senior ultrasonographists (P.C.L., E.M., L.C., V.A., S.R., J.K.) following the same protocol. Abdominal aorta echography and femoral artery ultrasonography examinations were performed by 1 ultrasonographist (J.K.). Coronary angiography was performed by senior interventional cardiologists (G.D., J.-M.J., L.F., P.G.S.), the results of which were stored on CD-ROM for off-line review. For all of these investigations, specific case report forms were completed immediately and collected by the clinical research assistants. The database concerning cross-sectional data was locked in April 2009. Prospective follow-up remains ongoing. Funding and sponsorship of the study were provided by SOS-ATTAQUE CEREBRALE Association (a nonprofit stroke survivor association).
Statistical Analysis
All statistical tests performed with the use of SAS software, version 9.1, were performed at the 2-tailed ␣ level of 0.05. Data are presented as mean (standard deviation) for continuous variables and percentage (count) for dichotomous variables. Among the overall study group, we studied the independent association of conventional coronary risk factors with coronary artery disease (plaques with or without stenosis, and stenoses Ն50%) using multiple logistic regression analysis. A modified Framingham global risk score 10 was determined using history of treated hypertension for the subset of 289 patients aged 30 to 74 years who had complete information on score components (age, gender, hypertension, total cholesterol, high-density lipoprotein cholesterol, current smoking, diabetes). We calculated the odds ratio (OR) of coronary artery disease per each point score increase in the Framingham global risk score using logistic regression analysis. We investigated the association of coronary artery disease with presence of plaques in the carotid artery, femoral artery, and aorta (arch, descending thoracic, and abdominal aorta) using logistic regression analysis adjusted for age and gender. An additional adjustment was performed by including risk factors associated with the presence of coronary artery disease (hypertension, dyslipidemia, current smoking, and family history of coronary heart disease) into the model. Because of the significant association of coronary artery disease with carotid and femoral plaques, we studied the joint effect of carotid and femoral plaques and computed the OR of coronary artery disease for presence of plaque in 1 arterial territory and in both arterial territories using patients with no plaque in carotid and femoral arteries as the control group. Finally, we investigated the association between coronary artery disease with the severity of carotid and aortic arch atherosclerosis. After pooling together the highest grade of carotid atherosclerosis, we calculated the OR of coronary artery disease for the presence of stenosis Ͻ50% and for the presence of stenosis Ն50% using patients with no carotid atherosclerosis as the reference group. Similarly, we calculated the OR of coronary artery disease for the presence of aortic arch plaque Ͻ4 mm and for the presence of aortic arch plaque Ն4 mm using patients with no aortic arch plaque as the reference group. To restrict the comparison to silent coronary lesions, all analyses were repeated after excluding patients with no known history of coronary heart disease.
Results
Between June 2005 and December 2008, 785 patients were assessed for eligibility and 405 patients with cerebral infarction were enrolled, of whom 15.6% (Nϭ63) had a known history of coronary heart disease (Supplemental Figure I available online at http://stroke.ahajournals.org). Among 342 patients with no known coronary heart disease, 315 (92.1%) underwent coronary angiography within a median of 8 (interquartile range, 6 -11) days after stroke onset; the remaining 27 patients (mean age, 67 years; 59% men) did not undergo coronary angiography (24 patients who refused after inclusion and 3 patients with contraindications) and were excluded from the analysis.
Prevalence of Asymptomatic Coronary Artery Disease
Among the 315 patients with no known coronary heart disease, coronary angiography was performed via the radial artery in 88.6% of cases (Nϭ279), via the femoral artery in 11.1% (Nϭ35), and required both in 0.3% (Nϭ1). No procedural adverse events occurred except for 1 groin hematoma. Table 1 shows the prevalence of asymptomatic coronary atherosclerosis by site and severity. Coronary plaques were found in 61.9% (95% confidence interval [CI], 56.5-67.3) of patients and coronary stenoses Ն50% were found in at least 1 vessel in 25.7% (95% CI, 20.9 -30.5). Forty-seven (14.9%) patients had at least 1 coronary stenosis Ն70%, of whom 10 had a complete occlusion. As shown in Figure 1 , the prevalence of 3-vessel coronary artery disease was 30.8% (Nϭ97), compared with 5.1% (Nϭ16) when only silent stenoses Ն50% were considered.
Coronary Artery Disease and Vascular Risk Factors
The demographic and clinical characteristics of the 378 patients who underwent coronary angiography or had a history of coronary heart disease are described in Table 2 . They were categorized according to the results of coronary angiography (no disease, silent stenosis Ͻ50%, and silent stenosis Ն50%) or to the presence of known history of coronary heart disease. In multivariable analysis, older age, male gender, hypertension, dyslipidemia, current smoking, and family history of coronary heart disease were independently associated with the presence of coronary plaque (ie, silent plaque regardless of arterial lumen reduction or known Figure 1 . Prevalence of asymptomatic coronary artery disease by number of diseased vessels among 315 patients with no history of coronary heart disease. *Regardless of stenosis severity. †Plaque with arterial lumen reduction Ն50% in diameter. coronary heart disease) and with the presence of coronary stenosis Ն50% (ie, silent stenosis Ն50% or known coronary heart disease; Figure 2 ). Consistent results were found when multivariable analysis was repeated in the subset of 315 patients with no known coronary heart disease ( Figure 2 
Coronary Artery Disease and Burden of Systemic Atherosclerosis
Among 378 patients, 98.7% (Nϭ373) underwent carotid ultrasonography examination; 93.4% of patients (Nϭ353) had a femoral examination, 89.4% (Nϭ338) had an abdominal aorta examination, and 79.1% (Nϭ299) had transesophageal echocardiography examination of the thoracic aorta. Table 3 shows the distribution of coronary artery disease according to the presence or absence of atherosclerotic plaque in each of these arterial territories. After adjustment for age and gender, the prevalence of coronary plaque was higher in the presence than in the absence of atherosclerotic plaque in the carotid artery (78% vs 58%; PϽ0.001), femoral artery (78% vs 46%; PϽ0.001), abdominal aorta (79% vs 66%; Pϭ0.06), aortic arch (75% vs 63%; Pϭ0.04), and descending thoracic aorta (80% vs 66%; Pϭ0.05).
In multivariable analysis, including age, gender, hypertension, dyslipidemia, current smoking, and family history of coronary heart disease, the presence of coronary plaque was significantly associated with the presence of plaque in the carotid and femoral arteries ( Figure 3A) . Similar results were Coronary plaque defined as silent plaque regardless of stenosis degree or known coronary heart disease. Coronary stenosis Ն50% defined as silent plaque with arterial lumen reduction Ն50% or known coronary heart disease. Black squares indicate multivariable-adjusted odds ratios (OR) computed in all study patients (Nϭ378), and gray squares indicate the multivariable-adjusted OR computed in patients with no known coronary heart disease (Nϭ315).
found when restricting the analysis to coronary stenoses Ն50% ( Figure 3B ) or to patients with no known coronary heart disease ( Figures 3A, B) . We therefore studied the interrelation between carotid, femoral, and coronary artery disease (Figure 4) . The prevalence of coronary plaque and prevalence of coronary stenosis Ն50% were markedly increased when plaques were present in both territories. The age-and gender-adjusted positive and negative predictive values of the presence of atherosclerotic plaque in both territories for predicting the presence of coronary plaque were 84% and 44%, respectively. The corresponding adjusted predictive values for the presence of coronary stenoses Ն50% were 45% and 74%, respectively. After adjustment for risk factors for coronary artery disease, the OR for having coronary plaque was 1.25 (95% CI, 0.58 -2.71) for patients with plaque in 1 extracardiac arterial location and 4.31 (95% CI, 1.92-9.68) for those with both extracardiac arterial locations compared to patients without evidence of extracardiac arterial disease. The corresponding adjusted OR of having a coronary stenosis were 1.57 (95% CI, 0.57-4.34) and 2.68 (95% CI, 1.00 -7.16), respectively. Similar adjusted OR were found in an analysis restricted to patients with no known coronary heart disease (data not shown). Figure 3 . Association between systemic atherosclerosis burden and coronary plaque (A) and coronary stenosis Ն50% (B). Coronary plaque defined as silent plaque regardless of stenosis degree or known coronary heart disease. Coronary stenosis Ն50% defined as silent plaque with arterial lumen reduction Ն50% or known coronary heart disease. Black squares indicate the adjusted odds ratios (OR) computed in all study patients (Nϭ378), and gray squares indicate the adjusted OR computed in patients with no known coronary heart disease (Nϭ315). Model 1, Logistic regression analysis adjusted for age and gender. Model 2, Logistic regression analysis adjusted for age, gender, hypertension, dyslipidemia, current smoking, and family history of coronary heart disease.
Coronary Artery Disease and Severity of Extracardiac Atherosclerosis
We found a marked increase in the prevalence of coronary plaque (especially in those with arterial lumen reduction of Ն50%) with increasing severity of carotid atherosclerosis ( Figure 5 ). Using patients without carotid plaque as the reference group, the age-and gender-adjusted OR for the presence of coronary plaque were 2.10 (95% CI, 1.23-3.59) for carotid stenoses Ͻ50% and 5.88 (95% CI, 2.38 -14.50) for carotid stenoses Ն50%. This relationship was not modified after additional adjustment for risk factors, with an OR of 1.95 (95% CI, 1.09 -3.50) for carotid stenosis Ͻ50% and 4.52 (95% CI, 1.78 -11.51) for stenosis Ն50%. When only coronary stenoses Ն50% were considered, consistent trends were observed (adjusted P for trend Ͻ0.001). An analysis restricted to patients with no known coronary heart disease yielded similar results (adjusted P for trend Ͻ0.005 for both coronary plaque and coronary stenosis Ն50%).
After categorization of atherosclerosis in the aortic arch into 3 groups (absence, plaque Ͻ4 mm, and plaque Ն4 mm), the presence of aortic arch plaque Ն4 mm (but not that of aortic arch plaque Ͻ4 mm) was associated with the presence of coronary plaque: fully adjusted OR 2.77 (95% CI, 1.01-7.58) for the presence of aortic arch plaque Ն4 mm and 1.02 (95% CI, 0.53-1.94) for presence of aortic arch plaque Ͻ4 mm. However, we found no association of coronary stenosis Ն50% with aortic arch plaque Ն4 mm (adjusted OR, 1.34; 95% CI, 0.62-2.90) and with aortic arch plaque Ͻ4 mm (OR, 0.61; 95% CI, 0.31-1.20). Similar results were found when analyses were restricted to patients with no known coronary heart disease (data not shown).
Discussion
Based on systematic coronary angiography in a large series of consecutive patients with a nonfatal cerebral infarction and no known coronary heart disease, this study documents a high prevalence of coronary atherosclerosis. Previous studies were based on exercise electrocardiograms or myocardial scintigraphy in patients with stroke or transient ischemic attack. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] These small series suggested a prevalence of silent myocardial ischemia as high as 40%. In the present study, which, to our knowledge, is the largest ever using gold standard coronary angiography in nonfatal ischemic strokes, the 62% prevalence of coronary artery plaque and the 26% prevalence of coronary artery stenosis Ն50% was consistent with the 70% prevalence and 29% prevalence, respectively, found in a previous autopsy series of fatal stroke without coronary heart disease history. 9 Intravascular ultrasound would have been more sensitive than angiography but was not considered feasible to maintain the consecutive inclusion of patients in this study. Although cardiac CT angiography has been found to be as effective as conventional coronary angiography in detecting coronary stenosis Ն50%, radiation exposure is significantly greater and it is not sufficiently accurate to warrant replacing coronary angiography. 23 The high burden of coronary artery disease in patients with cerebral infarction and no known coronary heart disease points to the importance of secondary prevention of coronary heart disease. It has been shown recently that routine revascularization does not improve major clinical outcomes compared with intensive medical therapy in stable coronary heart disease, but it improves symptom control. 24, 25 Therefore, despite our findings, there will be no need to systematically image coronary arteries in patients with cerebral infarction, unless patients are symptomatic or have evidence of ischemia on noninvasive tests.
In past years, stroke has been advocated as the preferred primary end point in secondary stroke prevention trials of antiplatelet agents, arguing that stroke is the most common event after a stroke. 26 Our study strengthens the case that randomized, controlled trials evaluating drugs that control risk factors or platelet inhibition should focus not only on stroke events but also on the sample size, which should be powered to detect an effect on major coronary events. 27 Contrary to short-term (1.5-3 years) antiplatelet trials that found a significant reduction in the stroke end point and no significant effect on major coronary events, 28 -32 long-term (4 -5 years) blood pressure or lipid-lowering trials have shown large reductions in rates of major coronary events in patients with stroke. 33, 34 This was exemplified in the SPARCL trial, which had included only stroke patients with no known coronary heart disease. 34 We could also assess the relationships between systemic atherosclerosis burden and that of coronary atherosclerosis. We found a significant association between the presence of coronary artery disease and carotid and femoral atherosclerosis in the overall group, including patients with either known or no known history of coronary heart disease. Analyses restricted to the group with silent coronary atherosclerosis (ie, no known coronary heart disease) found the same trends. Multiple territory disease has been shown to predict higher global risk in the REACH registry. 35 In the present study, having both femoral and carotid artery plaques was a good predictor of the presence of coronary artery disease ( Figure 5) , with a positive predictive value of 84% for coronary artery plaque. However, there was also a poor negative predictive value for coronary artery plaque of 44%, indicating that even in the absence of systemic atherosclerotic disease there was a high burden of coronary plaques. We could not confirm that aortic arch plaques Ն4 mm also predicted the presence of coronary artery disease (Figure 3) , as we and others 36 -39 have previously shown that they predict stroke and recurrent vascular events.
This study has limitations and strengths. It was limited by the lack of an age-and gender-matched control group. However, collecting a large sample of controls with coronary angiography would have been technically difficult; our previous autopsy study was case-controlled with a prevalence of coronary artery disease of 27% and of coronary stenosis Ն50% of 10% in the control group. 8 In the context of multiple testing, our findings should be interpreted with caution. Our study was not population-based, but it was hospital-based in one of the largest stroke units in Paris, France, working as a primary care referral center for acute stroke admissions with a dedicated catchment area. The baseline characteristics of our population are in line with what can be expected in the general population. Thus, it gives a fair evaluation of coronary atherosclerotic burden in patients with nonfatal cerebral infarction. By providing a complete, clear assessment of the presence and absence of atherosclerotic plaque in the 3 territories (carotid, femoral, and coronary artery), we can firmly conclude on the yield of carotid and femoral ultrasonography evaluation in predicting coronary artery disease. In conclusion, patients with cerebral infarction have a high burden of coronary atherosclerosis, even in the absence of known history of coronary heart disease or of systemic atherosclerosis.
